CTC
ARIA

Central Trust Company’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Central Trust Company’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-500
Closed -$3K – 1240
2015
Q3 		$3K Buy
+500
New +$3.85K ﹤0.01% 1135
2015
Q2 		– Sell
-1,000
Closed -$8K – 1251
2015
Q1 		$8K Buy
1,000
+300
+43% +$2.22K ﹤0.01% 1031
2014
Q4 		$5K Buy
+700
New +$4.38K ﹤0.01% 1092

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Central Trust Company's ARIA Position: Q4 2015 in Review

Central Trust Company sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2015, closing a stake of 500 shares — an estimated $3K sold.

Central Trust Company first reported a position in ARIA in Q4 2014 and held it in 3 quarters. The position peaked at $8K in Q1 2015. 172 funds tracked by Wall St. Rank hold ARIA as of Q4 2015.

  • Central Trust Company reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Central Trust Company sold 500 Ariad Pharmaceuticals Inc shares in Q4 2015, an estimated $3K.
  • Central Trust Company first reported a position in Ariad Pharmaceuticals Inc in Q4 2014 and held it in 3 quarters.
  • Central Trust Company's Ariad Pharmaceuticals Inc position peaked at $8K in Q1 2015.
  • 172 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2015.

Based on Central Trust Company's 13F filing for Q4 2015, filed 21 Jan 2016.